Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy

Pancreas Diseases

GSK3β(high)/NFATc1(high) subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair

Gut

Latif MU, Liu X, Bockelmann A, Huhnold L, Schmidt GE, Klein L, Zhao X, Conradi LC, Conrads K, Weber AL, Mercan S, Reutlinger K, Paul A, Najafova Z, Johnsen SA, Bonilla Del Rio Z, Penz F, Todorovic J, Bastians H, Beissbarth T, Sax U, Ashry R, Krämer OH, Hessmann E, Schneider G, Stroebel P, Bogeski I, Singh SK, Ellenrieder V

doi: 10.1136/gutjnl-2025-336227

Gastrointestinal Cancer

Investigating the causal effect of potential therapeutic agents for colorectal cancer prevention: a Mendelian randomization analysis

Cancer Epidemiol Biomarkers Prev

Fryer E, Bishop DT, Campbell PT, Chan AT, Le Marchand L, Li CI, Moreno V, Gunter MJ, Phipps AI, Grant RC, Schmit SL, Martin RM, Yarmolinsky J, Haycock P

doi: 10.1158/1055-9965.EPI-25-0875

ColonoscopyGastrointestinal Cancer

Effect of cecal intubation rate on post colonoscopy colorectal cancer deaths and detection of colorectal cancer precursors

Clin Gastroenterol Hepatol

Zessner-Spitzenberg J, Waldmann E, Rockenbauer LM, Demschik A, Klinger A, Penz D, Trauner M, Ferlitsch M

doi: 10.1016/j.cgh.2025.01.035

Gastrointestinal Cancer

Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study

Eur J Cancer

Kim HJ, Park JH, Hong JY, Han K, Shen JJ, Park JO, Park YS, Lim HY

doi: 10.1016/j.ejca.2025.116111

Gastrointestinal Cancer

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Cancer Epidemiol Biomarkers Prev

Peila R, Manson JE, Rohan TE

doi: 10.1158/1055-9965.EPI-25-0745

Gastrointestinal Cancer

Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate-Risk Countries-A Systematic Review and Meta-Analysis

United European Gastroenterol J

Mourato MB, Pratas N, Branco Pereira A, Chança R, Fronteira I, Dinis R, Areia M

doi: 10.1002/ueg2.70084

Inflammatory Bowel Disease

Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study

J Crohns Colitis

Privitera G, Bezzio C, Buono AD, Gabbiadini R, Loy L, Ranucci L, Bertin L, Masoni B, Migliorisi G, Sauta E, Delleani M, Savevski V, Porta MD, D'amico S, Armuzzi A

doi: 10.1093/ecco-jcc/jjaf239

Pancreas Diseases

Safety and Effectiveness of Cholecystectomy and Endoscopic Retrograde Cholangiopancreatography in Biliary Pancreatitis During Pregnancy: BORN Study

United European Gastroenterol J

Tarján D, Szalai EÁ, Erőss B, Hegyi PJ, Drug VL, Chooklin S, Hirth M, Sandblom G, Sandblom V, Edergren Å, Tlili A, Fendri S, Sirtl S, de la Iglesia Gracía D, Kurti F, Wu D, Gherbon A, Nawacki Ł, Constantinescu A, Shirinskaya NV, Zolotov AN, Pandanaboyana S, Ikeura T, Cúrdia Gonçalves T, Rasmussen L, Andersson B, Bouzid A, Saidani A, Ács N, Sipos Z, Farkas N, Tihanyi B, Teutsch B, Nilsson J, Mikó A, Hegyi P

doi: 10.1002/ueg2.70121

Inflammatory Bowel Disease

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease

Insights Imaging

Sakai NS, Plumb AA, Ahmed N, Chowdhury K, Kilic Y, Hameed M, Patel A, Bhagwanani A, Helbren E, Hyland R, Bhatnagar G, Sidhu H, Lambie H, Franklin JM, Mohsin M, Thomson E, Boone D, Tolan D, Rahman S, Ding N, Moran GW, Bloom S, Hart A, Menys A, Travis S, Halligan S, Taylor SA, Motility trial investigators

doi: 10.1186/s13244-025-01930-w

Related content

GSK3β(high)/NFATc1(high) subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair

Investigating the causal effect of potential therapeutic agents for colorectal cancer prevention: a Mendelian randomization analysis

Effect of cecal intubation rate on post colonoscopy colorectal cancer deaths and detection of colorectal cancer precursors

Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Effectiveness of Gastric Cancer Endoscopic Screening in Intermediate-Risk Countries-A Systematic Review and Meta-Analysis

Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study

Safety and Effectiveness of Cholecystectomy and Endoscopic Retrograde Cholangiopancreatography in Biliary Pancreatitis During Pregnancy: BORN Study

MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease